Arrhythmias & electrophysiology

Timing of anticoagulation restart after serious bleeding in atrial fibrillation

HeartPublished Nationwide Danish registries

Main finding · StrokeResult — go to the resultHazard ratio 0.89 95% CI 0.74–1.08

Authors' conclusion

Restarting DOACs early after a serious bleeding event in AF patients may reduce stroke risk but is associated with an increased risk of recurrent bleeding. DOAC monotherapy appears to offer the best stroke protection, though with elevated bleeding risk. These findings highlight the need for individualised decision-making and further trials to define optimal timing for DOAC resumption.

Study context

Population
Atrial fibrillation (AF) patients (CHA₂DS₂-VASc score ≥2) who experienced a first serious bleeding event while on DOAC therapy, Danish registries 2012–2021patients who survived 60 days postbleeding
Participants
10,291 patients
Exposure
Timing of DOAC restart: within 60 days vs after 60 days
  • Early restartersn = 5,970
  • Late restartersn = 4,321reference
Outcome
Stroke
Methodological detailsmultivariable Cox models, secondary analysis across six time-varying antithrombotic treatment regimens
  • Multivariable Cox models
  • Secondary analysis across six time-varying antithrombotic treatment regimens

Main finding

As reported in the abstract

Hazard ratio

0.89

95% CI 0.74–1.08

Early restartersvs late restarters
HR 0.89 (95% CI 0.74–1.08)

Observational data: associations, not effects.

Further findings

OutcomeHR (95% CI)
Stroke (time-varying analysis)DOAC monotherapyvs no treatmentReduced stroke risk with DOAC monotherapy0.78 (0.68–0.89)

Safety

OutcomeHR (95% CI)
Recurrent bleedingEarly restartersvs late restartersMore frequent in early restarters1.21 (1.07–1.36)
Bleeding (time-varying analysis)DOAC monotherapyvs no treatmentHigher during DOAC monotherapy1.26 (1.15–1.38)

Original publication

Timing of anticoagulation restart after serious bleeding in atrial fibrillation. Heart. Published 16 July 2025. doi:10.1136/heartjnl-2024-325343

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.